ロード中...
Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a heterogeneous malignancy closely related to metabolic reprogramming. We investigated how CTNNB1 mutation regulates the HCC metabolic phenotype and thus affects the prognosis of HCC. We obtained the mRNA expression profiles and clinicopathological data from The Can...
保存先:
| 出版年: | J Cell Mol Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7812275/ https://ncbi.nlm.nih.gov/pubmed/33300278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16181 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|